QuickView for 3%27%2C5%27-cyclic-AMP phosphodiesterase activity (biogroup)

1. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
4. Lungs of smokers with and without COPD - miRNA expression
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

1. Gene set analysis of purine and pyrimidine antimetabolites cancer therapies.
2. Effects of an extract of Ginkgo biloba on the 3',5'-cyclic AMP phosphodiesterase activity of the bra…
3. An effect of glucagon on 3', 5'-cyclic AMP phosphodiesterase activity in isolated rat hepatocytes.
4. Rapid assays for adenylate cyclase and 3',5' cyclic AMP phosphodiesterase activities. Simultaneous m…
5. Demonstration of 3'5'-cyclic AMP phosphodiesterase activity in the human placenta at term].

There were no clinical trials for 3%27%2C5%27-cyclic-AMP phosphodiesterase activity